For help on how to get the results you want, see our search tips.
1226 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Categories
Human Remove Human filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Sildenafil Actavis (updated)
sildenafil, Erectile Dysfunction
Date of authorisation: 10/12/2009,
, Revision: 14, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Zubsolv (updated)
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate, Opioid-Related Disorders
Date of authorisation: 10/11/2017, Revision: 6, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Kalydeco (updated)
ivacaftor, Cystic Fibrosis
Date of authorisation: 23/07/2012,
, 
, Revision: 28, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Memantine Mylan (updated)
memantine hydrochloride, Alzheimer Disease
Date of authorisation: 21/04/2013,, Revision: 7, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Aclasta (updated)
zoledronic acid, Osteoporosis, Osteitis Deformans, Osteoporosis, Postmenopausal
Date of authorisation: 15/04/2005, Revision: 28, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Glivec (updated)
imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Gastrointestinal Stromal Tumors, Dermatofibrosarcoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome
Date of authorisation: 07/11/2001,
, Revision: 41, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Orgalutran (updated)
ganirelix, Reproductive Techniques, Assisted, Ovulation Induction
Date of authorisation: 16/05/2000, Revision: 22, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Axura (updated)
memantine hydrochloride, Alzheimer Disease
Date of authorisation: 17/05/2002, Revision: 25, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Fosavance (updated)
alendronic acid, colecalciferol, Osteoporosis, Postmenopausal
Date of authorisation: 24/08/2005, Revision: 25, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Aerinaze (updated)
desloratadine, pseudophedrine sulfate, Rhinitis, Allergic, Seasonal
Date of authorisation: 30/07/2007, Revision: 19, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Increlex (updated)
Mecasermin, Laron Syndrome
Date of authorisation: 02/08/2007,, 
, Revision: 22, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Brilique (updated)
ticagrelor, Peripheral Vascular Diseases, Acute Coronary Syndrome
Date of authorisation: 03/12/2010, Revision: 16, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Lyumjev (previously Liumjev) (updated)
insulin lispro, Diabetes Mellitus
Date of authorisation: 24/03/2020,, Revision: 3, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Atectura Breezhaler (updated)
indacaterol acetate, Mometasone furoate, Asthma
Date of authorisation: 30/05/2020, Revision: 2, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine Janssen (updated)
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S), COVID-19 virus infection
Date of authorisation: 11/03/2021,, 
, Revision: 2, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Comirnaty (updated)
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020,, , Revision: 6, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (updated)
ChAdOx1-SARS-COV-2, COVID-19 virus infection
Date of authorisation: 29/01/2021,, , Revision: 6, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Vitrakvi (updated)
larotrectinib sulfate, Abdominal Neoplasms
Date of authorisation: 19/09/2019,, , Revision: 3, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Sylvant (updated)
siltuximab, Giant Lymph Node Hyperplasia
Date of authorisation: 22/05/2014,, , Revision: 11, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Enerzair Breezhaler (updated)
indacaterol, glycopyrronium bromide, mometasone, Asthma
Date of authorisation: 03/07/2020, Revision: 1, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Nexavar (updated)
sorafenib, Carcinoma, Hepatocellular, Carcinoma, Renal Cell
Date of authorisation: 19/07/2006,, Revision: 29, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Viread (updated)
tenofovir disoproxil fumarate, Hepatitis B, Chronic, HIV Infections
Date of authorisation: 04/02/2002, Revision: 56, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Intelence (updated)
Etravirine, HIV Infections
Date of authorisation: 28/08/2008, Revision: 26, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Xtandi (updated)
enzalutamide, Prostatic Neoplasms
Date of authorisation: 21/06/2013,
Date of refusal: 26/04/2013, Revision: 18, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Copalia (updated)
valsartan, amlodipine (as amlodipine besilate), Hypertension
Date of authorisation: 15/01/2007, Revision: 25, Authorised, Last updated: 12/05/2021